Quantcast

Latest Pulmonology Stories

2014-10-17 08:25:14

ANDOVER, Mass., Oct. 17, 2014 /PRNewswire/ -- ndd Medical Technologies, a leader in innovative mobile pulmonary function testing (PFT) employing precise ultrasound technology, announced that its EasyOne Pro® is now being used by the Choctaw Nation Healthcare Center, a 140,000 square foot, 44-bed hospital with many outpatient services. The Talihina, Oklahoma hospital serves a large number of Native Americans from several tribes living in southeastern Oklahoma and beyond. A portion of...

2014-10-16 12:30:21

First FDA Approved Treatments in United States for Devastating Lung Disease Affecting More than 200,000 Americans, with Survival Rate of Just Three to Five Years CHICAGO, Oct. 16, 2014 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) applauds the approval of Esbriet(®) (pirfenidone) and OFEV(®) (nintedanib) by the U.S. Food and Drug Administration (FDA) as the first disease-specific therapies for idiopathic pulmonary fibrosis (IPF) in the United States....

2014-10-15 12:31:48

The COPD Market Will Fracture with the Continuing Entry of LABA/LAMAs and Other Later-to-Market Bronchodilators, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 15, 2014 /PRNewswire/ -- Decision Resources Group finds that the emergence of the long-acting beta(2) agonist (LABA)/long-acting muscarinic antagonist (LAMA) drug class will help drive total sales across the chronic obstructive pulmonary disease (COPD) market in the United States, France, Germany, Italy,...

2014-10-15 08:30:43

NIH Awards Two Grants to Academic Partners to Progress Mucolytic Research Program DURHAM, N.C., Oct. 15, 2014 /PRNewswire-USNewswire/ -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced today that the National Institutes of Health (NIH) has awarded up to $15.6 million over 5 years in grants to The University of North Carolina, Chapel Hill (UNC-CH) and The University of Colorado, Denver (UCD) to conduct research...

2014-10-14 20:23:15

-New Yorkers with Severe Lung Diseases, Here is Your Rescue! SEOUL, South Korea, Oct. 14, 2014 /PRNewswire/ -- "About 123,000 patients with atopic dermatitis, rhinitis, and asthma and 32,000 patients with pulmonary emphysema, bronchiectasis, and pulmonary fibrosis have been cured." http://photos.prnewswire.com/prnvar/20141014/151916 There is a Korean medicine doctor who has cured hundred thousands of lives of patients with chronic allergic conditions, only with Korean medicine. He...

2014-10-13 23:02:07

On Monday, October 20, Regenerative Medicine Solutions (RMS) is set to open its doors to two new clinics in Nashville, Tennessee. RMS welcomes the launch of an entirely new facility, the Sleep Apnea Institute, and the expansion of a new treatment center for the Lung Institute. Tampa, FL (PRWEB) October 13, 2014 On Monday, October 20, Regenerative Medicine Solutions (RMS) is set to open its doors to two new clinics in Nashville, Tennessee. RMS welcomes the launch of an entirely new...

2014-10-13 20:23:12

ORLANDO, Fla., Oct. 13, 2014 /PRNewswire/ -- Nephron Pharmaceuticals Corporation received certification as a woman-owned business by the National Women Business Owners Corporation (NWBOC), the first certifier of Women Business Enterprises. The certification gives Nephron enhanced visibility and a new competitive edge. "Nephron is excited for the recognition of being certified as a woman-owned business in October, the same month that salutes all things pink," says Mrs. Lou Kennedy,...

2014-10-09 08:27:25

AUSTIN, Texas, Oct. 9, 2014 /PRNewswire/ -- International Biophysics Corporation of Austin, Texas announces its filing of U.S. patent protection for its revolutionary AffloVest®. The company has also recently confirmed exclusive ownership rights concerning the manufacture, sale and distribution of the AffloVest in its markets. The AffloVest® is the first self-contained, truly portable High Frequency Chest Wall Oscillation (HFCWO) vest available in the United States, having both...

2014-10-08 12:26:37

Emerging Anticytokines, Are Expected to Drive the Market Growth and Open a New Era of Personalized Medicine in Asthma, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 8, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for asthma will remain stable, increasing slightly from $15.1 billion in 2013 to $16.1 billion in 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan. As the current market leaders, which...

2014-10-08 08:26:47

RIDGEFIELD, Conn., Oct. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that Striverdi® Respimat® (olodaterol) Inhalation Spray 5 mcg is now available by prescription in pharmacies across the United States. STRIVERDI RESPIMAT is a long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. STRIVERDI RESPIMAT is not indicated to treat asthma...


Latest Pulmonology Reference Libraries

0_f9fe10c6664d20ba0d9091907b66a65f
2011-01-05 16:00:36

Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...

More Articles (1 articles) »
Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.